Tumorigenicity decrease in Bcl-xL deficient MDCK cells ensuring the safety for influenza vaccine production. Zheng J, Li B, Jia L, Zhang J, et al. PLoS One 2024;19:e0311069.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zheng J, Li B, Jia L, Zhang J, et al. Tumorigenicity decrease in Bcl-xL deficient MDCK cells ensuring the safety for influenza vaccine production. PLoS One 2024;19:e0311069.
PMID: 39680522